Abstract:The anti-cholinesterase activity exhibited by several organophosphorus compounds brings interest to the development of new antidotes for poisoning cases with such chemicals. The advance of more efficient methods for destruction of stockpiles of chemical warfare agents is also currently important. In this sense, the aim of this work is to present a review of the recent progress in the investigation of the reactivity of phosphate triesters in several different systems, which can give insights into the developmen… Show more
“…This path should be the least favorable one with imidazole (no reports to date) 19,21 and occurs predominantly with alpha-nucleophiles. 25 In order to infer how the reactions occur, a thorough kinetic study was carried out as well as it was followed by 1 H and 31 P NMR, to confirm possible intermediates and products.…”
Is the broad mechanistic versatility of imidazole towards organophosphates (OPs), that has inspired many catalysts and sensors, beneficial? Herein, a thorough analysis is given seeking to unravel this puzzle. For OPs from the P=O family, imidazole attacks the phosphorus atom exclusively (N-phosphorylates). With the P=S family which are less reactive, an unusual N-alkylation predominates. Surprisingly, imidazole reacts with methyl parathion exclusively at the aliphatic carbon, whilst for the ethylated analogue parathion, imidazole reacts by two pathways: at both the phosphorus and aliphatic carbon, with predominance for the latter. The preference for the electrophilic center can be modulated by the pH. Overall, a mechanistic structure-related trend is observed: imidazole tends to prefer other electrophilic centers than the phosphorus for less reactive OPs. Moreover, this gives important insights concerning the challenging chemistry of imidazole alkylation and the outcomes for monitoring systems that depend on the detection of degradation products. Finally, a thorough comparison with the literature is presented seeking to understand how imidazole reacts towards various OPs. We suggest that the promiscuity of imidazole boosts up its versatility.
“…This path should be the least favorable one with imidazole (no reports to date) 19,21 and occurs predominantly with alpha-nucleophiles. 25 In order to infer how the reactions occur, a thorough kinetic study was carried out as well as it was followed by 1 H and 31 P NMR, to confirm possible intermediates and products.…”
Is the broad mechanistic versatility of imidazole towards organophosphates (OPs), that has inspired many catalysts and sensors, beneficial? Herein, a thorough analysis is given seeking to unravel this puzzle. For OPs from the P=O family, imidazole attacks the phosphorus atom exclusively (N-phosphorylates). With the P=S family which are less reactive, an unusual N-alkylation predominates. Surprisingly, imidazole reacts with methyl parathion exclusively at the aliphatic carbon, whilst for the ethylated analogue parathion, imidazole reacts by two pathways: at both the phosphorus and aliphatic carbon, with predominance for the latter. The preference for the electrophilic center can be modulated by the pH. Overall, a mechanistic structure-related trend is observed: imidazole tends to prefer other electrophilic centers than the phosphorus for less reactive OPs. Moreover, this gives important insights concerning the challenging chemistry of imidazole alkylation and the outcomes for monitoring systems that depend on the detection of degradation products. Finally, a thorough comparison with the literature is presented seeking to understand how imidazole reacts towards various OPs. We suggest that the promiscuity of imidazole boosts up its versatility.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.